Loading...
Header Logo
Keywords
Last Name
Institution

Mr Michael Dean Green

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Green M, Otieno K, Katana A, Slutsker L, Kariuki S, Ouma P, González R, Menendez C, ter Kuile F, Desai M. Pharmacokinetics of mefloquine and its effect on sulfamethoxazole and trimethoprim steady-state blood levels in intermittent preventive treatment (IPTp) of pregnant HIV-infected women in Kenya. Malar J. 2016 Jan 05; 15:7. PMID: 26732683; PMCID: PMC4700759.
    2. Kaur H, Allan EL, Mamadu I, Hall Z, Ibe O, El Sherbiny M, van Wyk A, Yeung S, Swamidoss I, Green MD, Dwivedi P, Culzoni MJ, Clarke S, Schellenberg D, Fernández FM, Onwujekwe O. Quality of artemisinin-based combination formulations for malaria treatment: prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, Nigeria. PLoS One. 2015; 10(5):e0125577. PMID: 26018221; PMCID: PMC4446036.
    3. Quadros Gomes BA, da Silva LF, Quadros Gomes AR, Moreira DR, Dolabela MF, Santos RS, Green MD, Carvalho EP, Percário S. N-acetyl cysteine and mushroom Agaricus sylvaticus supplementation decreased parasitaemia and pulmonary oxidative stress in a mice model of malaria. Malar J. 2015 May 15; 14:202. PMID: 25971771; PMCID: PMC4435846.
    4. Yong YL, Plançon A, Lau YH, Hostetler DM, Fernández FM, Green MD, Sounvoravong S, Nara S, Boravann M, Dumrong T, Bangsawan N, Low MY, Lim CC, Ai RL, Newton PN. Collaborative health and enforcement operations on the quality of antimalarials and antibiotics in southeast Asia. Am J Trop Med Hyg. 2015 Jun; 92(6 Suppl):105-12. PMID: 25897069; PMCID: PMC4455084.
    5. Yeung S, Lawford HL, Tabernero P, Nguon C, van Wyk A, Malik N, DeSousa M, Rada O, Boravann M, Dwivedi P, Hostetler DM, Swamidoss I, Green MD, Fernandez FM, Kaur H. Quality of antimalarials at the epicenter of antimalarial drug resistance: results from an overt and mystery client survey in Cambodia. Am J Trop Med Hyg. 2015 Jun; 92(6 Suppl):39-50. PMID: 25897063; PMCID: PMC4455075.
    6. Tabernero P, Mayxay M, Culzoni MJ, Dwivedi P, Swamidoss I, Allan EL, Khanthavong M, Phonlavong C, Vilayhong C, Yeuchaixiong S, Sichanh C, Sengaloundeth S, Kaur H, Fernández FM, Green MD, Newton PN. A Repeat Random Survey of the Prevalence of Falsified and Substandard Antimalarials in the Lao PDR: A Change for the Better. Am J Trop Med Hyg. 2015 Jun; 92(6 Suppl):95-104. PMID: 25897062; PMCID: PMC4455074.
    7. Green MD, Hostetler DM, Nettey H, Swamidoss I, Ranieri N, Newton PN. Integration of novel low-cost colorimetric, laser photometric, and visual fluorescent techniques for rapid identification of falsified medicines in resource-poor areas: application to artemether-lumefantrine. Am J Trop Med Hyg. 2015 Jun; 92(6 Suppl):8-16. PMID: 25897066; PMCID: PMC4455085.
    8. Newton PN, Schellenberg D, Ashley EA, Ravinetto R, Green MD, ter Kuile FO, Tabernero P, White NJ, Guerin PJ. Quality assurance of drugs used in clinical trials: proposal for adapting guidelines. BMJ. 2015 Feb 25; 350:h602. PMID: 25716700.
      View in: PubMed
    9. Huang SX, Green MD, de Carvalho AT, Mumau M, Chen YW, D'Souza SL, Snoeck HW. The in vitro generation of lung and airway progenitor cells from human pluripotent stem cells. Nat Protoc. 2015 Mar; 10(3):413-25. PMID: 25654758; PMCID: PMC4654940.
    10. Ranieri N, Tabernero P, Green MD, Verbois L, Herrington J, Sampson E, Satzger RD, Phonlavong C, Thao K, Newton PN, Witkowski MR. Evaluation of a new handheld instrument for the detection of counterfeit artesunate by visual fluorescence comparison. Am J Trop Med Hyg. 2014 Nov; 91(5):920-4. PMID: 25266348; PMCID: PMC4228888.
    11. Newton PN, Tabernero P, Dwivedi P, Culzoni MJ, Monge ME, Swamidoss I, Mildenhall D, Green MD, Jähnke R, de Oliveira Mdos S, Simao J, White NJ, Fernández FM. Falsified medicines in Africa: all talk, no action. Lancet Glob Health. 2014 Sep; 2(9):e509-10. PMID: 25304415.
      View in: PubMed
    12. Huang SX, Islam MN, O'Neill J, Hu Z, Yang YG, Chen YW, Mumau M, Green MD, Vunjak-Novakovic G, Bhattacharya J, Snoeck HW. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat Biotechnol. 2014 Jan; 32(1):84-91. PMID: 24291815; PMCID: PMC4101921.
    13. Kesselheim AS, Green MD, Avorn J. Who is now responsible for discovering and warning about adverse effects of generic drugs? JAMA. 2013 Sep 11; 310(10):1023-4. PMID: 23922000.
      View in: PubMed
    14. El Demellawy D, Robison JG, Pollack IF, Green MD, Alper CM, Reyes-Múgica M. Idiopathic intervertebral disc calcification in childhood: an atypical case of an uncommon entity for pediatric pathologists. Pediatr Dev Pathol. 2013 Nov-Dec; 16(6):432-7. PMID: 23901810.
      View in: PubMed
    15. Green MD, Mayxay M, Beach R, Pongvongsa T, Phompida S, Hongvanthong B, Vanisaveth V, Newton PN, Vizcaino L, Swamidoss I. Evaluation of a rapid colorimetric field test to assess the effective life of long-lasting insecticide-treated mosquito nets in the Lao PDR. Malar J. 2013 Feb 07; 12:57. PMID: 23391349; PMCID: PMC3623780.
    16. Percário S, Moreira DR, Gomes BA, Ferreira ME, Gonçalves AC, Laurindo PS, Vilhena TC, Dolabela MF, Green MD. Oxidative stress in malaria. Int J Mol Sci. 2012 Dec 03; 13(12):16346-72. PMID: 23208374; PMCID: PMC3546694.
    17. Green MD, Huang SX, Snoeck HW. Stem cells of the respiratory system: from identification to differentiation into functional epithelium. Bioessays. 2013 Mar; 35(3):261-70. PMID: 23175215.
      View in: PubMed
    18. Graf PC, Durand S, Alvarez Antonio C, Montalvan C, Galves Montoya M, Green MD, Santolalla ML, Salas C, Lucas C, Bacon DJ, Fryauff DJ. Failure of Supervised Chloroquine and Primaquine Regimen for the Treatment of Plasmodium vivax in the Peruvian Amazon. Malar Res Treat. 2012; 2012:936067. PMID: 22701198; PMCID: PMC3371340.
    19. Longmire TA, Ikonomou L, Hawkins F, Christodoulou C, Cao Y, Jean JC, Kwok LW, Mou H, Rajagopal J, Shen SS, Dowton AA, Serra M, Weiss DJ, Green MD, Snoeck HW, Ramirez MI, Kotton DN. Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells. Cell Stem Cell. 2012 Apr 06; 10(4):398-411. PMID: 22482505; PMCID: PMC3322392.
    20. Newton PN, Green MD, Mildenhall DC, Plançon A, Nettey H, Nyadong L, Hostetler DM, Swamidoss I, Harris GA, Powell K, Timmermans AE, Amin AA, Opuni SK, Barbereau S, Faurant C, Soong RC, Faure K, Thevanayagam J, Fernandes P, Kaur H, Angus B, Stepniewska K, Guerin PJ, Fernández FM. Poor quality vital anti-malarials in Africa - an urgent neglected public health priority. Malar J. 2011 Dec 13; 10:352. PMID: 22152094; PMCID: PMC3262771.
    21. Green MD, Snoeck HW. Novel approaches for immune reconstitution and adaptive immune modeling with human pluripotent stem cells. BMC Med. 2011 May 10; 9:51. PMID: 21569275; PMCID: PMC3098795.
    22. Picarsic J, Jaffe R, Mazariegos G, Webber SA, Ellis D, Green MD, Reyes-Múgica M. Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder. Cancer. 2011 Oct 01; 117(19):4540-50. PMID: 21446044.
      View in: PubMed
    23. Green MD, Chen A, Nostro MC, d'Souza SL, Schaniel C, Lemischka IR, Gouon-Evans V, Keller G, Snoeck HW. Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells. Nat Biotechnol. 2011 Mar; 29(3):267-72. PMID: 21358635; PMCID: PMC4866999.
    24. Fernandez FM, Hostetler D, Powell K, Kaur H, Green MD, Mildenhall DC, Newton PN. Poor quality drugs: grand challenges in high throughput detection, countrywide sampling, and forensics in developing countries. Analyst. 2011 Aug 07; 136(15):3073-82. PMID: 21107455; PMCID: PMC3427017.
    25. Hernandez BY, Green MD, Cassel KD, Pobutsky AM, Vu V, Wilkens LR. Preview of Hawaii Cancer Facts and Figures 2010. Hawaii Med J. 2010 Sep; 69(9):223-4. PMID: 20848386; PMCID: PMC3071205.
    26. Whitman TJ, Coyne PE, Magill AJ, Blazes DL, Green MD, Milhous WK, Burgess TH, Freilich D, Tasker SA, Azar RG, Endy TP, Clagett CD, Deye GA, Shanks GD, Martin GJ. An outbreak of Plasmodium falciparum malaria in U.S. Marines deployed to Liberia. Am J Trop Med Hyg. 2010 Aug; 83(2):258-65. PMID: 20682864; PMCID: PMC2911167.
    27. Pérez JJ, Harris GA, Chipuk JE, Brodbelt JS, Green MD, Hampton CY, Fernández FM. Transmission-mode direct analysis in real time and desorption electrospray ionization mass spectrometry of insecticide-treated bednets for malaria control. Analyst. 2010 Apr; 135(4):712-9. PMID: 20309445.
      View in: PubMed
    28. Newton PN, Green MD, Fernández FM. Impact of poor-quality medicines in the 'developing' world. Trends Pharmacol Sci. 2010 Mar; 31(3):99-101. PMID: 20117849; PMCID: PMC2845817.
    29. Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, Green MD, Jha V, Josephson MA, Kiberd BA, Kreis HA, McDonald RA, Newmann JM, Obrador GT, Vincenti FG, Cheung M, Earley A, Raman G, Abariga S, Wagner M, Balk EM. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int. 2010 Feb; 77(4):299-311. PMID: 19847156.
      View in: PubMed
    30. Lee SW, Lee M, Lee DD, Kim C, Kim YJ, Kim JY, Green MD, Klein TA, Kim HC, Nettey H, Ko DH, Kim H, Park I. Biological resistance of hydroxychloroquine for Plasmodium vivax malaria in the Republic of Korea. Am J Trop Med Hyg. 2009 Oct; 81(4):600-4. PMID: 19815873.
      View in: PubMed
    31. Sengaloundeth S, Green MD, Fernández FM, Manolin O, Phommavong K, Insixiengmay V, Hampton CY, Nyadong L, Mildenhall DC, Hostetler D, Khounsaknalath L, Vongsack L, Phompida S, Vanisaveth V, Syhakhang L, Newton PN. A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR - implications for therapeutic failure and drug resistance. Malar J. 2009 Jul 28; 8:172. PMID: 19638225; PMCID: PMC2734859.
    32. Green MD, Francis PA, Gebski V, Harvey V, Karapetis C, Chan A, Snyder R, Fong A, Basser R, Forbes JF. Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer. Ann Oncol. 2009 Nov; 20(11):1813-7. PMID: 19553291.
      View in: PubMed
    33. Colleoni M, Sun Z, Martinelli G, Basser RL, Coates AS, Gelber RD, Green MD, Peccatori F, Cinieri S, Aebi S, Viale G, Price KN, Goldhirsch A. The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up. Ann Oncol. 2009 Aug; 20(8):1344-51. PMID: 19468030; PMCID: PMC2720817.
    34. Newton PN, Lee SJ, Goodman C, Fernández FM, Yeung S, Phanouvong S, Kaur H, Amin AA, Whitty CJ, Kokwaro GO, Lindegårdh N, Lukulay P, White LJ, Day NP, Green MD, White NJ. Guidelines for field surveys of the quality of medicines: a proposal. PLoS Med. 2009 Mar 24; 6(3):e52. PMID: 19320538; PMCID: PMC2659710.
    35. Green MD, Atieli F, Akogbeto M. Rapid colorimetric field test to determine levels of deltamethrin on PermaNet surfaces: association with mosquito bioactivity. Trop Med Int Health. 2009 Apr; 14(4):381-8. PMID: 19254275.
      View in: PubMed
    36. Nyadong L, Hohenstein EG, Johnson K, Sherrill CD, Green MD, Fernández FM. Desorption electrospray ionization reactions between host crown ethers and the influenza neuraminidase inhibitor oseltamivir for the rapid screening of Tamiflu. Analyst. 2008 Nov; 133(11):1513-22. PMID: 18936828.
      View in: PubMed
    37. Dowell FE, Maghirang EB, Fernandez FM, Newton PN, Green MD. Detecting counterfeit antimalarial tablets by near-infrared spectroscopy. J Pharm Biomed Anal. 2008 Nov 04; 48(3):1011-4. PMID: 18703302.
      View in: PubMed
    38. Keoluangkhot V, Green MD, Nyadong L, Fernández FM, Mayxay M, Newton PN. Impaired clinical response in a patient with uncomplicated falciparum malaria who received poor-quality and underdosed intramuscular artemether. Am J Trop Med Hyg. 2008 Apr; 78(4):552-5. PMID: 18385347.
      View in: PubMed
    39. Green MD, Nettey H, Wirtz RA. Determination of oseltamivir quality by colorimetric and liquid chromatographic methods. Emerg Infect Dis. 2008 Apr; 14(4):552-6. PMID: 18394271; PMCID: PMC2570928.
    40. Newton PN, Fernández FM, Plançon A, Mildenhall DC, Green MD, Ziyong L, Christophel EM, Phanouvong S, Howells S, McIntosh E, Laurin P, Blum N, Hampton CY, Faure K, Nyadong L, Soong CW, Santoso B, Zhiguang W, Newton J, Palmer K. A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia. PLoS Med. 2008 Feb; 5(2):e32. PMID: 18271620; PMCID: PMC2235893.
    41. Nyadong L, Late S, Green MD, Banga A, Fernández FM. Direct quantitation of active ingredients in solid artesunate antimalarials by noncovalent complex forming reactive desorption electrospray ionization mass spectrometry. J Am Soc Mass Spectrom. 2008 Mar; 19(3):380-8. PMID: 18187340.
      View in: PubMed
    42. Bernhard J, Zahrieh D, Zhang JJ, Martinelli G, Basser R, Hürny C, Forbes JF, Aebi S, Yeo W, Thürlimann B, Green MD, Colleoni M, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Coates AS. Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer. Br J Cancer. 2008 Jan 15; 98(1):25-33. PMID: 18043579; PMCID: PMC2359705.
    43. Green MD, van Eijk AM, van Ter Kuile FO, Ayisi JG, Parise ME, Kager PA, Nahlen BL, Steketee R, Nettey H. Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya. J Infect Dis. 2007 Nov 01; 196(9):1403-8. PMID: 17922406.
      View in: PubMed
    44. Ng R, Green MD. Managing cardiotoxicity in anthracycline-treated breast cancers. Expert Opin Drug Saf. 2007 May; 6(3):315-21. PMID: 17480180.
      View in: PubMed
    45. Newton PN, Green MD, Fernandez F. Counterfeit artemisinin derivatives and Africa: update from authors. PLoS Med. 2007 Mar 27; 4(3):e139. PMID: 17388677; PMCID: PMC1831749.
    46. Nyadong L, Green MD, De Jesus VR, Newton PN, Fernández FM. Reactive desorption electrospray ionization linear ion trap mass spectrometry of latest-generation counterfeit antimalarials via noncovalent complex formation. Anal Chem. 2007 Mar 01; 79(5):2150-7. PMID: 17269655.
      View in: PubMed
    47. Hall KA, Newton PN, Green MD, De Veij M, Vandenabeele P, Pizzanelli D, Mayxay M, Dondorp A, Fernandez FM. Characterization of counterfeit artesunate antimalarial tablets from southeast Asia. Am J Trop Med Hyg. 2006 Nov; 75(5):804-11. PMID: 17123969.
      View in: PubMed
    48. Green MD. Antimalarial drug resistance and the importance of drug quality monitoring. J Postgrad Med. 2006 Oct-Dec; 52(4):288-90. PMID: 17102548.
      View in: PubMed
    49. Newton PN, Green MD, Fernández FM, Day NP, White NJ. Counterfeit anti-infective drugs. Lancet Infect Dis. 2006 Sep; 6(9):602-13. PMID: 16931411.
      View in: PubMed
    50. Green MD, Nettey H, Villalva Rojas O, Pamanivong C, Khounsaknalath L, Grande Ortiz M, Newton PN, Fernández FM, Vongsack L, Manolin O. Use of refractometry and colorimetry as field methods to rapidly assess antimalarial drug quality. J Pharm Biomed Anal. 2007 Jan 04; 43(1):105-10. PMID: 16930916.
      View in: PubMed
    51. Fernández FM, Cody RB, Green MD, Hampton CY, McGready R, Sengaloundeth S, White NJ, Newton PN. Characterization of solid counterfeit drug samples by desorption electrospray ionization and direct-analysis-in-real-time coupled to time-of-flight mass spectrometry. ChemMedChem. 2006 Jul; 1(7):702-5. PMID: 16902921.
      View in: PubMed
    52. Newton PN, McGready R, Fernandez F, Green MD, Sunjio M, Bruneton C, Phanouvong S, Millet P, Whitty CJ, Talisuna AO, Proux S, Christophel EM, Malenga G, Singhasivanon P, Bojang K, Kaur H, Palmer K, Day NP, Greenwood BM, Nosten F, White NJ. Manslaughter by fake artesunate in Asia--will Africa be next? PLoS Med. 2006 Jun; 3(6):e197. PMID: 16752952; PMCID: PMC1475657.
    53. Hartz A, Green MD, Yoho R, Lee H. A new tool for assessing standard of care in medical malpractice cases. Plast Reconstr Surg. 2006 Apr 15; 117(5):1632-7. PMID: 16641735.
      View in: PubMed
    54. Green MD, Beall B, Marcon MJ, Allen CH, Bradley JS, Dashefsky B, Gilsdorf JR, Schutze GE, Smith C, Walter EB, Martin JM, Edwards KM, Barbadora KA, Wald ER. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA. J Antimicrob Chemother. 2006 Jun; 57(6):1240-3. PMID: 16556634.
      View in: PubMed
    55. Farrell DJ, Shackcloth J, Barbadora KA, Green MD. Streptococcus pyogenes isolates with high-level macrolide resistance and reduced susceptibility to telithromycin associated with 23S rRNA mutations. Antimicrob Agents Chemother. 2006 Feb; 50(2):817-8. PMID: 16436755; PMCID: PMC1366915.
    56. Ng R, Better N, Green MD. Anticancer agents and cardiotoxicity. Semin Oncol. 2006 Feb; 33(1):2-14. PMID: 16473642.
      View in: PubMed
    57. Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95. J Clin Oncol. 2006 Jan 20; 24(3):370-8. PMID: 16421418.
      View in: PubMed
    58. Green MD. Causation, Vioxx, and legal issues. Science. 2005 Nov 11; 310(5750):973. PMID: 16284163.
      View in: PubMed
    59. Graber MA, Hartz A, James P, Nugent A, Green MD. An alternative method of determining standard of care in alleged cases of malpractice. J Am Board Fam Pract. 2005 Nov-Dec; 18(6):453-8. PMID: 16322408.
      View in: PubMed
    60. Ng R, de Boer R, Green MD. Undertreatment of elderly patients with non-small-cell lung cancer. Clin Lung Cancer. 2005 Nov; 7(3):168-74. PMID: 16354310.
      View in: PubMed
    61. Ng R, Green MD. Pegfilgrastim: evidence in support of its use with cytotoxic chemotherapy. Expert Rev Anticancer Ther. 2005 Aug; 5(4):585-90. PMID: 16111460.
      View in: PubMed
    62. Dondorp AM, Newton PN, Mayxay M, Van Damme W, Smithuis FM, Yeung S, Petit A, Lynam AJ, Johnson A, Hien TT, McGready R, Farrar JJ, Looareesuwan S, Day NP, Green MD, White NJ. Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials. Trop Med Int Health. 2004 Dec; 9(12):1241-6. PMID: 15598255.
      View in: PubMed
    63. Artenstein AW, Opal SM, Cristofaro P, Palardy JE, Parejo NA, Green MD, Jhung JW. Chloroquine enhances survival in Bacillus anthracis intoxication. J Infect Dis. 2004 Nov 01; 190(9):1655-60. PMID: 15478072.
      View in: PubMed
    64. Wong S, Rosenthal MA, deBoer R, Green MD, Fox RM. Five years managing metastatic non-small cell lung cancer: experience at a teaching hospital. Intern Med J. 2004 Aug; 34(8):458-63. PMID: 15317543.
      View in: PubMed
    65. Green MD, D'Souza MJ, Holbrook JM, Wirtz RA. In vitro and in vivo evaluation of albumin-encapsulated primaquine diphosphate prepared by nebulization into heated oil. J Microencapsul. 2004 Jun; 21(4):433-44. PMID: 15513749.
      View in: PubMed
    66. Hall MA, Green MD, Hartz A. Evidence-based medicine on trial. JAMA. 2004 Apr 14; 291(14):1697; author reply 1698. PMID: 15082690.
      View in: PubMed
    67. Hall MA, Green MD. Malpractice litigation reform: empirical approaches to establishing the legal standard of care. J Med Pract Manage. 2004 Mar-Apr; 19(5):279-82. PMID: 15152917.
      View in: PubMed
    68. Meza LA, Green MD, Hackett JR, Neumann TA, Holmes FA. Filgrastim-mediated neutrophil recovery in patients with breast cancer treated with docetaxel and doxorubicin. Pharmacotherapy. 2003 Nov; 23(11):1424-31. PMID: 14620389.
      View in: PubMed
    69. Gunawardana DH, Basser RL, Davis ID, Cebon J, Mitchell P, Underhill C, Kilpatrick TJ, Reardon K, Green MD, Bardy P, Amor P, Crump D, Ng S, Nation RL, Begley CG. A phase I study of recombinant human leukemia inhibitory factor in patients with advanced cancer. Clin Cancer Res. 2003 Jun; 9(6):2056-65. PMID: 12796368.
      View in: PubMed
    70. Kubista E, Glaspy J, Holmes FA, Green MD, Hackett J, Neumann T. Bone pain associated with once-per-cycle pegfilgrastim is similar to daily filgrastim in patients with breast cancer. Clin Breast Cancer. 2003 Feb; 3(6):391-8. PMID: 12636878.
      View in: PubMed
    71. Vats A, Shapiro R, Singh Randhawa P, Scantlebury V, Tuzuner A, Saxena M, Moritz ML, Beattie TJ, Gonwa T, Green MD, Ellis D. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation. 2003 Jan 15; 75(1):105-12. PMID: 12544881.
      View in: PubMed
    72. Green MD, Koelbl H, Baselga J, Galid A, Guillem V, Gascon P, Siena S, Lalisang RI, Samonigg H, Clemens MR, Zani V, Liang BC, Renwick J, Piccart MJ. A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy. Ann Oncol. 2003 Jan; 14(1):29-35. PMID: 12488289.
      View in: PubMed
    73. Rosenthal MA, Rischin D, McArthur G, Ribbons K, Chong B, Fareed J, Toner G, Green MD, Basser RL. Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia. Ann Oncol. 2002 May; 13(5):770-6. PMID: 12075747.
      View in: PubMed
    74. Newton PN, White NJ, Rozendaal JA, Green MD. Murder by fake drugs. BMJ. 2002 Apr 06; 324(7341):800-1. PMID: 11934760; PMCID: PMC1122752.
    75. Green MD, Mount DL, Nettey H. High-performance liquid chromatographic assay for the simultaneous determination of sulfadoxine and pyrimethamine from whole blood dried onto filter paper. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Feb 05; 767(1):159-62. PMID: 11863287.
      View in: PubMed
    76. MacArthur J, Stennies GM, Macheso A, Kolczak MS, Green MD, Ali D, Barat LM, Kazembe PN, Ruebush TK. Efficacy of mefloquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum infection in Machinga District, Malawi, 1998. Am J Trop Med Hyg. 2001 Dec; 65(6):679-84. PMID: 11791956.
      View in: PubMed
    77. Green MD, Mount DL, Wirtz RA. Authentication of artemether, artesunate and dihydroartemisinin antimalarial tablets using a simple colorimetric method. Trop Med Int Health. 2001 Dec; 6(12):980-2. PMID: 11737833.
      View in: PubMed
    78. Tjandra JJ, Reading DM, McLachlan SA, Gunn IF, Green MD, McLaughlin SJ, Millar JL, Pedersen JS. Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer: preliminary results. Dis Colon Rectum. 2001 Aug; 44(8):1113-22. PMID: 11535850.
      View in: PubMed
    79. Coffman BL, Kearney WR, Green MD, Lowery RG, Tephly TR. Analysis of opioid binding to UDP-glucuronosyltransferase 2B7 fusion proteins using nuclear magnetic resonance spectroscopy. Mol Pharmacol. 2001 Jun; 59(6):1464-9. PMID: 11353807.
      View in: PubMed
    80. Rosenthal MA, Kavar B, Hill JS, Morgan DJ, Nation RL, Stylli SS, Basser RL, Uren S, Geldard H, Green MD, Kahl SB, Kaye AH. Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin. J Clin Oncol. 2001 Jan 15; 19(2):519-24. PMID: 11208846.
      View in: PubMed
    81. Green MD, Mount DL, Wirtz RA, White NJ. A colorimetric field method to assess the authenticity of drugs sold as the antimalarial artesunate. J Pharm Biomed Anal. 2000 Dec; 24(1):65-70. PMID: 11108540.
      View in: PubMed
    82. Sanchez JL, Bendet I, Grogl M, Lima JB, Pang LW, Guimaraes MF, Guedes CM, Milhous WK, Green MD, Todd GD. Malaria in Brazilian military personnel deployed to Angola. J Travel Med. 2000 Sep-Oct; 7(5):275-82. PMID: 11231212.
      View in: PubMed
    83. Basser RL, Underhill C, Davis I, Green MD, Cebon J, Zalcberg J, MacMillan J, Cohen B, Marty J, Fox RM, Begley CG. Enhancement of platelet recovery after myelosuppressive chemotherapy by recombinant human megakaryocyte growth and development factor in patients with advanced cancer. J Clin Oncol. 2000 Aug; 18(15):2852-61. PMID: 10920133.
      View in: PubMed
    84. Davis ID, Maher DW, Cebon JS, Green MD, Fox RM, McKendrick JJ, Rybak ME, Boyd AW. A phase I and pharmacokinetic study of subcutaneously-administered recombinant human interleukin-4 (rhuIL-4) in patients with advanced cancer. Growth Factors. 2000; 17(4):287-300. PMID: 10801077.
      View in: PubMed
    85. Clarke K, Basser RL, Underhill C, Mitchell P, Bartlett J, Cher L, Findlay M, Dalley D, Pell M, Byrne M, Geldard H, Hill JS, Maher D, Fox RM, Green MD, Kaye AH. KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade glioma. J Clin Oncol. 1999 Aug; 17(8):2579-84. PMID: 10561325.
      View in: PubMed
    86. Talbot SM, Westerman DA, Grigg AP, Toner GC, Wolf M, Bishop J, McKendrick J, Zalcberg J, Levi J, Fox RM, Green MD. Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumors. Ann Oncol. 1999 Aug; 10(8):907-14. PMID: 10509151.
      View in: PubMed
    87. Green MD, Bergqvist Y, Mount DL, Corbett S, D'Souza MJ. Improved validated assay for the determination of mefloquine and its carboxy metabolite in plasma, serum and whole blood using solid-phase extraction and high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 1999 Apr 30; 727(1-2):159-65. PMID: 10360435.
      View in: PubMed
    88. Ooi BS, Tjandra JJ, Green MD. Morbidities of adjuvant chemotherapy and radiotherapy for resectable rectal cancer: an overview. Dis Colon Rectum. 1999 Mar; 42(3):403-18. PMID: 10223765.
      View in: PubMed
    89. Basser RL, To LB, Collins JP, Begley CG, Keefe D, Cebon J, Bashford J, Durrant S, Szer J, Kotasek D, Juttner CA, Russell I, Maher DW, Olver I, Sheridan WP, Fox RM, Green MD. Multicycle high-dose chemotherapy and filgrastim-mobilized peripheral-blood progenitor cells in women with high-risk stage II or III breast cancer: five-year follow-up. J Clin Oncol. 1999 Jan; 17(1):82-92. PMID: 10458221.
      View in: PubMed
    90. Basser RL, Abraham R, To LB, Fox RM, Green MD. Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer. Ann Oncol. 1999 Jan; 10(1):53-8. PMID: 10076722.
      View in: PubMed
    91. Green MD. Prescription drugs, alternative designs, and the Restatement (Third): preliminary reflections. Seton Hall Law Rev. 1999; 30(1):207-32. PMID: 10848103.
      View in: PubMed
    92. Cheng Z, Rios GR, King CD, Coffman BL, Green MD, Mojarrabi B, Mackenzie PI, Tephly TR. Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7. Toxicol Sci. 1998 Sep; 45(1):52-7. PMID: 9848110.
      View in: PubMed
    93. Clarke K, Basser RL, Maher D, Morgan DJ, Cebon J, Fox RM, Hill JS, Alt C, Bartlett J, Geldard H, Kaye AH, Green MD. Phase I and pharmacokinetic study of KRN8602 alone and with filgrastim in patients with advanced cancer. J Clin Oncol. 1998 Jun; 16(6):2181-7. PMID: 9626219.
      View in: PubMed
    94. Green MD, King CD, Mojarrabi B, Mackenzie PI, Tephly TR. Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metab Dispos. 1998 Jun; 26(6):507-12. PMID: 9616184.
      View in: PubMed
    95. Shen J, Moy JA, Green MD, Guengerich FP, Baron J. Immunohistochemical demonstration of beta-naphthoflavone-inducible cytochrome P450 1A1/1A2 in rat intrahepatic biliary epithelial cells. Hepatology. 1998 Jun; 27(6):1483-91. PMID: 9620317.
      View in: PubMed
    96. Basser RL, To LB, Begley CG, Maher D, Juttner C, Cebon J, Mansfield R, Olver I, Duggan G, Szer J, Collins J, Schwartz B, Marty J, Menchaca D, Sheridan WP, Fox RM, Green MD. Rapid hematopoietic recovery after multicycle high-dose chemotherapy: enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factor. J Clin Oncol. 1998 May; 16(5):1899-908. PMID: 9586908.
      View in: PubMed
    97. Wald ER, Green MD, Schwartz B, Barbadora K. A streptococcal score card revisited. Pediatr Emerg Care. 1998 Apr; 14(2):109-11. PMID: 9583390.
      View in: PubMed
    98. Thomas DM, Seymour JF, Szer J, Grigg AP, Basser RL, Green MD, Fox RM. Progress in management of acute myeloid leukaemia (AML) in Australia since 1980: a single institution retrospective study. Aust N Z J Med. 1998 Apr; 28(2):190-6. PMID: 9612527.
      View in: PubMed
    99. Kurtis JD, Koros JK, Duffy PE, Green MD. Malaria prevention for travelers. JAMA. 1998 Apr 01; 279(13):990-1. PMID: 9533489.
      View in: PubMed
    100. Morgan DJ, Hill JS, Clarke K, Stylli SS, Park SJ, Cebon J, Basser RL, Kaye AH, Geldard H, Maher DW, Green MD. Effect of filgrastim on the pharmacokinetics of MX2 hydrochloride in patients with advanced malignant disease. Cancer Chemother Pharmacol. 1998; 41(5):423-6. PMID: 9523740.
      View in: PubMed
    101. Tephly TR, Green MD, Coffman BL, King C, Cheng Z, Rios G. Metabolism of endobiotics and xenobiotics by UDP-glucuronosyltransferase. Adv Pharmacol. 1998; 42:343-6. PMID: 9327911.
      View in: PubMed
    102. Green MD, Bélanger G, Hum DW, Bélanger A, Tephly TR. Glucuronidation of opioids, carboxylic acid-containing drugs, and hydroxylated xenobiotics catalyzed by expressed monkey UDP-glucuronosyltransferase 2B9 protein. Drug Metab Dispos. 1997 Dec; 25(12):1389-94. PMID: 9394029.
      View in: PubMed
    103. Begley CG, Basser R, Mansfield R, Thomson B, Parker WR, Layton J, To B, Cebon J, Sheridan WP, Fox RM, Green MD. Enhanced levels and enhanced clonogenic capacity of blood progenitor cells following administration of stem cell factor plus granulocyte colony-stimulating factor to humans. Blood. 1997 Nov 01; 90(9):3378-89. PMID: 9345020.
      View in: PubMed
    104. Todd GD, Hopperus Buma AP, Green MD, Jaspers CA, Lobel HO. Comparison of whole blood and serum levels of mefloquine and its carboxylic acid metabolite. Am J Trop Med Hyg. 1997 Oct; 57(4):399-402. PMID: 9347952.
      View in: PubMed
    105. Green MD. Oral bisphosphonates and malignancy. Med J Aust. 1997 Aug 18; 167(4):211-2. PMID: 9293269.
      View in: PubMed
    106. Basser RL, Rasko JE, Clarke K, Cebon J, Green MD, Grigg AP, Zalcberg J, Cohen B, O'Byrne J, Menchaca DM, Fox RM, Begley CG. Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer. Blood. 1997 May 01; 89(9):3118-28. PMID: 9129014.
      View in: PubMed
    107. King CD, Rios GR, Green MD, MacKenzie PI, Tephly TR. Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds. Drug Metab Dispos. 1997 Feb; 25(2):251-5. PMID: 9029056.
      View in: PubMed
    108. Morgan DJ, Hill JS, Clarke K, Stylli SS, Park SJ, Cebon J, Basser RL, Kaye AH, Geldard H, Maher DW, Green MD. Pharmacokinetics and pharmacodynamics of MX2 hydrochloride in patients with advanced malignant disease. Cancer Chemother Pharmacol. 1997; 40(3):202-8. PMID: 9219502.
      View in: PubMed
    109. Martinasevic MK, Green MD, Baron J, Tephly TR. Folate and 10-formyltetrahydrofolate dehydrogenase in human and rat retina: relation to methanol toxicity. Toxicol Appl Pharmacol. 1996 Dec; 141(2):373-81. PMID: 8975761.
      View in: PubMed
    110. Abraham R, Basser RL, Green MD. A risk-benefit assessment of anthracycline antibiotics in antineoplastic therapy. Drug Saf. 1996 Dec; 15(6):406-29. PMID: 8968695.
      View in: PubMed
    111. Basser RL, Rasko JE, Clarke K, Cebon J, Green MD, Hussein S, Alt C, Menchaca D, Tomita D, Marty J, Fox RM, Begley CG. Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. Lancet. 1996 Nov 09; 348(9037):1279-81. PMID: 8909381.
      View in: PubMed
    112. O'Malley CJ, Rasko JE, Basser RL, McGrath KM, Cebon J, Grigg AP, Hopkins W, Cohen B, O'Byrne J, Green MD, Fox RM, Berndt MC, Begley CG. Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. Blood. 1996 Nov 01; 88(9):3288-98. PMID: 8896392.
      View in: PubMed
    113. Mount DL, Green MD, Zucker JR, Were JB, Todd GD. Field detection of sulfonamides in urine: the development of a new and sensitive test. Am J Trop Med Hyg. 1996 Sep; 55(3):250-3. PMID: 8842109.
      View in: PubMed
    114. King CD, Green MD, Rios GR, Coffman BL, Owens IS, Bishop WP, Tephly TR. The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1. Arch Biochem Biophys. 1996 Aug 01; 332(1):92-100. PMID: 8806713.
      View in: PubMed
    115. Hopperus Buma AP, van Thiel PP, Lobel HO, Ohrt C, van Ameijden EJ, Veltink RL, Tendeloo DC, van Gool T, Green MD, Todd GD, Kyle DE, Kager PA. Long-term malaria chemoprophylaxis with mefloquine in Dutch marines in Cambodia. J Infect Dis. 1996 Jun; 173(6):1506-9. PMID: 8648231.
      View in: PubMed
    116. Green MD, Clarke DJ, Oturu EM, Styczynski PB, Jackson MR, Burchell B, Tephly TR. Cloning and expression of a rat liver phenobarbital-inducible UDP-glucuronosyltransferase (2B12) with specificity for monoterpenoid alcohols. Arch Biochem Biophys. 1995 Oct 01; 322(2):460-8. PMID: 7574722.
      View in: PubMed
    117. Green MD, Mount DL, Todd GD. Determination of sulfadoxine concentrations in whole blood using C18 solid-phase extraction, sodium dodecyl sulfate and dimethylaminocinnamaldehyde. Analyst. 1995 Oct; 120(10):2623-6. PMID: 8540620.
      View in: PubMed
    118. Coffman BL, Green MD, King CD, Tephly TR. Cloning and stable expression of a cDNA encoding a rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 1.1) that catalyzes the glucuronidation of opioids and bilirubin. Mol Pharmacol. 1995 Jun; 47(6):1101-5. PMID: 7603447.
      View in: PubMed
    119. Green MD, Mount DL, Todd GD, Capomacchia AC. Chemiluminescent detection of artemisinin. Novel endoperoxide analysis using luminol without hydrogen peroxide. J Chromatogr A. 1995 Mar 31; 695(2):237-42. PMID: 7757205.
      View in: PubMed
    120. Green MD, Bishop WP, Tephly TR. Expressed human UGT1.4 protein catalyzes the formation of quaternary ammonium-linked glucuronides. Drug Metab Dispos. 1995 Mar; 23(3):299-302. PMID: 7628292.
      View in: PubMed
    121. Basser RL, Sobol MM, Duggan G, Cebon J, Rosenthal MA, Mihaly G, Green MD. Comparative study of the pharmacokinetics and toxicity of high-dose epirubicin with or without dexrazoxane in patients with advanced malignancy. J Clin Oncol. 1994 Aug; 12(8):1659-66. PMID: 8040678.
      View in: PubMed
    122. Sheridan WP, Begley CG, To LB, Grigg A, Szer J, Maher D, Green MD, Rowlings PA, McGrath KM, Cebon J, et al. Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies. Bone Marrow Transplant. 1994 Jul; 14(1):105-11. PMID: 7524904.
      View in: PubMed
    123. Basser RL, Green MD. Strategies for prevention of anthracycline cardiotoxicity. Cancer Treat Rev. 1993 Jan; 19(1):57-77. PMID: 8431927.
      View in: PubMed
    124. Rosenthal MA, Sheridan WP, Green MD, Liew K, Fox RM. Primary cerebral lymphoma: an argument for the use of adjunctive systemic chemotherapy. Aust N Z J Surg. 1993 Jan; 63(1):30-2. PMID: 8466457.
      View in: PubMed
    125. Green MD, Sherman P, Zalcberg J. Phase II study of 10-EdAM in patients with squamous cell carcinoma of the head and neck, previously untreated with chemotherapy. Invest New Drugs. 1992 Apr; 10(1):31-4. PMID: 1607252.
      View in: PubMed
    126. Farag SS, Green MD, Morstyn G, Sheridan WP, Fox RM. Delay by internists in obtaining diagnostic biopsies in patients with suspected cancer. Ann Intern Med. 1992 Mar 15; 116(6):473-8. PMID: 1310838.
      View in: PubMed
    127. Rosenthal MA, Green MD. Recent advances in parathyroid tumors and paragangliomas. Curr Opin Oncol. 1992 Feb; 4(1):99-104. PMID: 1317216.
      View in: PubMed
    128. Sobol MM, Amiet RG, Green MD. In vitro evidence for direct complexation of ADR-529/ICRF-187 [(+)-1,2-bis-(3,5-dioxo-piperazin-1-yl)propane] onto an existing ferric-anthracycline complex. Mol Pharmacol. 1992 Jan; 41(1):8-17. PMID: 1732725.
      View in: PubMed
    129. Hochster HS, Kim KM, Green MD, Mann RB, Neiman RS, Oken MM, Cassileth PA, Stott P, Ritch P, O'Connell MJ. Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study. J Clin Oncol. 1992 Jan; 10(1):28-32. PMID: 1727921.
      View in: PubMed
    130. Speyer JL, Green MD, Zeleniuch-Jacquotte A, Wernz JC, Rey M, Sanger J, Kramer E, Ferrans V, Hochster H, Meyers M, et al. ICRF-187 permits longer treatment with doxorubicin in women with breast cancer. J Clin Oncol. 1992 Jan; 10(1):117-27. PMID: 1727913.
      View in: PubMed
    131. Basser RL, Green MD, Sheridan WP, Fox RM. Pilot study of escalating doses of carboplatin and cyclophosphamide in patients with advanced cancer. Cancer Chemother Pharmacol. 1992; 30(2):161-3. PMID: 1600598.
      View in: PubMed
    132. Alderton PM, Gross J, Green MD. Comparative study of doxorubicin, mitoxantrone, and epirubicin in combination with ICRF-187 (ADR-529) in a chronic cardiotoxicity animal model. Cancer Res. 1992 Jan 01; 52(1):194-201. PMID: 1727379.
      View in: PubMed
    133. Basser RL, Lieschke GJ, Sheridan WP, Fox RM, Green MD. Recombinant alpha-2b interferon in patients with malignant carcinoid tumour. Aust N Z J Med. 1991 Dec; 21(6):875-8. PMID: 1726359.
      View in: PubMed
    134. Oziemski MA, Rockman SP, Marks DI, Green MD, Varigos GA, Fox RM. Extracorporeal photochemotherapy in the treatment of cutaneous T-cell lymphoma. Complexity of objective evaluation. Int J Dermatol. 1991 Nov; 30(11):814-7. PMID: 1757186.
      View in: PubMed
    135. Holmes A, Kilpatrick C, Proietto J, Green MD. Reversal of a neurologic paraneoplastic syndrome with octreotide (Sandostatin) in a patient with glucagonoma. Am J Med. 1991 Oct; 91(4):434-6. PMID: 1951389.
      View in: PubMed
    136. Basser RL, Green MD. Recent advances in carcinoids and gastrointestinal neuroendocrine tumors. Curr Opin Oncol. 1991 Feb; 3(1):109-20. PMID: 2043691.
      View in: PubMed
    137. Millington DS, Norwood DL, Kodo N, Moore R, Green MD, Berman J. Biomedical applications of high-performance liquid chromatography-mass spectrometry with continuous-flow fast atom bombardment. J Chromatogr. 1991 Jan 02; 562(1-2):47-58. PMID: 2026712.
      View in: PubMed
    138. Green MD, Alderton P, Sobol MM, Gross J, Muggia FM, Speyer JL. ICRF-187 (ADR-529) cardioprotection against anthracycline-induced cardiotoxicity: clinical and preclinical studies. Cancer Treat Res. 1991; 58:101-17. PMID: 1683780.
      View in: PubMed
    139. Speyer JL, Green MD, Sanger J, Zeleniuch-Jacquotte A, Kramer E, Rey M, Wernz JC, Blum RH, Hochester H, Meyers M, et al. A prospective randomized trial of ICRF-187 for prevention of cumulative doxorubicin-induced cardiac toxicity in women with breast cancer. Cancer Treat Rev. 1990 Sep; 17(2-3):161-3. PMID: 2125531.
      View in: PubMed
    140. Tjuljandin SA, Doig RG, Sobol MM, Watson DM, Sheridan WP, Morstyn G, Mihaly G, Green MD. Pharmacokinetics and toxicity of two schedules of high dose epirubicin. Cancer Res. 1990 Aug 15; 50(16):5095-101. PMID: 2379173.
      View in: PubMed
    141. Alderton P, Gross J, Green MD. Role of (+-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) in modulating free radical scavenging enzymes in doxorubicin-induced cardiomyopathy. Cancer Res. 1990 Aug 15; 50(16):5136-42. PMID: 2116226.
      View in: PubMed
    142. Coffman BL, Tephly TR, Irshaid YM, Green MD, Smith C, Jackson MR, Wooster R, Burchell B. Characterization and primary sequence of a human hepatic microsomal estriol UDPglucuronosyltransferase. Arch Biochem Biophys. 1990 Aug 15; 281(1):170-5. PMID: 2116769.
      View in: PubMed
    143. Green MD, Speyer JL, Wernz JC, Colombo N, Beller U, Muggia FM, Beckman EM. Phase II study of esorubicin (4'deoxydoxorubicin) in anthracycline naive patients with ovarian cancer. Invest New Drugs. 1990 Aug; 8(3):333-6. PMID: 2272774.
      View in: PubMed
    144. McCluskey MP, Clark CR, Talbot BG, Green MD, Lukey BJ. A high-performance liquid chromatographic assay for HI-6 oxime in plasma. J Anal Toxicol. 1990 Jul-Aug; 14(4):239-42. PMID: 2395347.
      View in: PubMed
    145. Offenbacher S, Odle BM, Green MD, Mayambala CS, Smith MA, Fritz ME, van Dyke TE, Yeh KC, Sena FJ. Inhibition of human periodontal prostaglandin E2 synthesis with selected agents. Agents Actions. 1990 Mar; 29(3-4):232-8. PMID: 2111080.
      View in: PubMed
    146. Green MD, Alderton P, Gross J, Muggia FM, Speyer JL. Evidence of the selective alteration of anthracycline activity due to modulation by ICRF-187 (ADR-529). Pharmacol Ther. 1990; 48(1):61-9. PMID: 2125733.
      View in: PubMed
    147. Bonomi PD, Finkelstein DM, Ruckdeschel JC, Blum RH, Green MD, Mason B, Hahn R, Tormey DC, Harris J, Comis R, et al. Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group. J Clin Oncol. 1989 Nov; 7(11):1602-13. PMID: 2553879.
      View in: PubMed
    148. Smith JA, Green MD, Russell IS, Collins JP. Sequential alternating medroxyprogesterone acetate and epirubicin in the treatment of advanced breast cancer. Aust N Z J Surg. 1989 Nov; 59(11):869-72. PMID: 2530970.
      View in: PubMed
    149. Sheridan WP, Morstyn G, Wolf M, Dodds A, Lusk J, Maher D, Layton JE, Green MD, Souza L, Fox RM. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet. 1989 Oct 14; 2(8668):891-5. PMID: 2477656.
      View in: PubMed
    150. Sheridan WP, Boyd AW, Green MD, Russell DM, Thomas RJ, McGrath KM, Vaughan SL, Scarlett JD, Griffiths JD, Brodie GN, et al. High-dose chemotherapy with busulphan and cyclophosphamide and bone-marrow transplantation for drug-sensitive malignancies in adults: a preliminary report. Med J Aust. 1989 Oct 02; 151(7):379-86. PMID: 2677622.
      View in: PubMed
    151. Petrelli N, Douglass HO, Herrera L, Russell D, Stablein DM, Bruckner HW, Mayer RJ, Schinella R, Green MD, Muggia FM, et al. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group. J Clin Oncol. 1989 Oct; 7(10):1419-26. PMID: 2674331.
      View in: PubMed
    152. Marks DI, Sheridan WP, Ellis DW, Boyd AW, Morstyn G, Green MD, Fox RM. Diffuse large cell lymphoma: a teaching hospital experience. Aust N Z J Med. 1989 Apr; 19(2):159-61. PMID: 2475099.
      View in: PubMed
    153. Lieschke GJ, Bell D, Rawlinson W, Green MD, Sheridan W, Morstyn G, Stuart-Harris R, Kefford RF, Levi J, Sorrell T, et al. Empiric single agent or combination antibiotic therapy for febrile episodes in neutropenic patients: an overview. Eur J Cancer Clin Oncol. 1989; 25 Suppl 2:S37-42. PMID: 2693108.
      View in: PubMed
    154. Speyer JL, Green MD, Kramer E, Rey M, Sanger J, Ward C, Dubin N, Ferrans V, Stecy P, Zeleniuch-Jacquotte A, et al. Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer. N Engl J Med. 1988 Sep 22; 319(12):745-52. PMID: 3137469.
      View in: PubMed
    155. Green MD, Speyer JL, Hochster HS, Liebes LF, Dunleavy S, Widman T, Wernz JC, Blum RH, Spiegel RJ, Muggia FM. Phase I trial of escalating dose doxorubicin administered concurrently with alpha 2-interferon. Cancer Res. 1988 May 01; 48(9):2574-8. PMID: 3356017.
      View in: PubMed
    156. Muggia FM, Camacho FJ, Kaplan BH, Green MD, Greenwald ES, Wernz JC, Engstrom PF. Weekly 5-fluorouracil combined with PALA: toxic and therapeutic effects in colorectal cancer. Cancer Treat Rep. 1987 Mar; 71(3):253-6. PMID: 3815391.
      View in: PubMed
    157. Green MD. Rationale and strategy for prevention of anthracycline cardiotoxicity with the bisdioxopiperazine, ICRF-187. Pathol Biol (Paris). 1987 Jan; 35(1):49-53. PMID: 3550612.
      View in: PubMed
    158. Hochster HS, Green MD, Speyer J, Fazzini E, Blum R, Muggia FM. 4'Epidoxorubicin (epirubicin): activity in hepatocellular carcinoma. J Clin Oncol. 1985 Nov; 3(11):1535-40. PMID: 2997408.
      View in: PubMed
    159. Speyer JL, Green MD, Dubin N, Blum RH, Wernz JC, Roses D, Sanger J, Muggia FM. Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast. Am J Med. 1985 Apr; 78(4):555-63. PMID: 3838618.
      View in: PubMed
    160. Green MD, Speyer JS, Bottino JC, Blum RH, Wernz JC, Muggia FM. Phase I-II study of the continuous infusion of doxorubicin in the treatment of non-small cell lung cancer. Cancer Treat Rep. 1984 Apr; 68(4):681-2. PMID: 6713422.
      View in: PubMed
    161. Sutherland RL, Reddel RR, Green MD. Effects of oestrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antioestrogens. Eur J Cancer Clin Oncol. 1983 Mar; 19(3):307-18. PMID: 6345171.
      View in: PubMed
    162. Green MD, MacKay IR, Buckley JC, Coates AS. The survival of patients with malignant melanoma receiving BCG with or without chemotherapy. Aust N Z J Surg. 1979 Jun; 49(3):335-9. PMID: 289374.
      View in: PubMed
    Green's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description